$TMNA
Tingo Inc

2023 Q3 Form 10-Q Financial Statement

#000141057823001928 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $0.00
YoY Change -100.0%
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $0.00
YoY Change -100.0%
Gross Profit Margin
Selling, General & Admin $11.22M
YoY Change -69.11%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change -100.0%
% of Gross Profit
Operating Expenses $11.22M
YoY Change -73.38%
Operating Profit -$11.22M
YoY Change -109.2%
Interest Expense $298.8K
YoY Change 1159.51%
% of Operating Profit
Other Income/Expense, Net -$1.049K
YoY Change -100.92%
Pretax Income -$11.22M
YoY Change -109.19%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$11.22M
YoY Change -115.47%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 1.228B 1.228B
Diluted Shares Outstanding 1.228B

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.57K
YoY Change -99.99%
Cash & Equivalents $13.57K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $20.07M
YoY Change -98.67%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.215B
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.215B
YoY Change 106.96%
TOTAL ASSETS
Total Short-Term Assets $20.07M
Total Long-Term Assets $1.215B
Total Assets $1.235B
YoY Change -41.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $955.4K
YoY Change
Accrued Expenses $4.485M
YoY Change 108.13%
Deferred Revenue
YoY Change
Short-Term Debt $23.77M
YoY Change 679.44%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $38.40M
YoY Change -95.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $38.40M
Total Long-Term Liabilities $0.00
Total Liabilities $38.40M
YoY Change -97.03%
SHAREHOLDERS EQUITY
Retained Earnings $788.7M
YoY Change 51.29%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.197B
YoY Change
Total Liabilities & Shareholders Equity $1.235B
YoY Change -41.21%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$11.22M
YoY Change -115.47%
Depreciation, Depletion And Amortization $0.00
YoY Change -100.0%
Cash From Operating Activities -$41.17K
YoY Change -100.44%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 22.50K
YoY Change -99.98%
NET CHANGE
Cash From Operating Activities -41.17K
Cash From Investing Activities
Cash From Financing Activities 22.50K
Net Change In Cash -18.67K
YoY Change -100.02%
FREE CASH FLOW
Cash From Operating Activities -$41.17K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
38398412
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1235313261
us-gaap Operating Income Loss
OperatingIncomeLoss
-30284205
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-138104239
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-46230485
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001648365
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Trading Symbol
TradingSymbol
IWBB
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-205835
dei Entity Registrant Name
EntityRegistrantName
AGRI-FINTECH HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-0549737
dei Entity Address Address Line1
EntityAddressAddressLine1
11650 South State
dei Entity Address Address Line2
EntityAddressAddressLine2
Street, Suite 240
dei Entity Address City Or Town
EntityAddressCityOrTown
Draper
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10010
dei City Area Code
CityAreaCode
385
dei Local Phone Number
LocalPhoneNumber
463-8168
dei Security12g Title
Security12gTitle
Class A Common Stock, $0.001 par value per share
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1227516211
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13568
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
985
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
20058693
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
19637668
CY2023Q2 us-gaap Assets Current
AssetsCurrent
20072261
CY2022Q4 us-gaap Assets Current
AssetsCurrent
19638653
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
1215241000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
1215241000
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1215241000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1215241000
CY2023Q2 us-gaap Assets
Assets
1235313261
CY2022Q4 us-gaap Assets
Assets
1234879653
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6460967
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4286181
CY2023Q2 tmna Advances Payable To Related Party Current
AdvancesPayableToRelatedPartyCurrent
465000
CY2022Q4 tmna Advances Payable To Related Party Current
AdvancesPayableToRelatedPartyCurrent
505000
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
23772445
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
23749945
CY2023Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
7700000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
28541126
CY2023Q2 us-gaap Liabilities
Liabilities
38398412
CY2022Q4 us-gaap Liabilities
Liabilities
28541126
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
419181135
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
419181135
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
788670116
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
818796244
CY2023Q2 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
12228918
CY2022Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
32931368
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1196914849
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1206338527
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1234879653
CY2022Q2 us-gaap Revenues
Revenues
268684899
us-gaap Revenues
Revenues
525742418
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
3114854
us-gaap Cost Of Revenue
CostOfRevenue
5614694
CY2022Q2 us-gaap Gross Profit
GrossProfit
265570045
us-gaap Gross Profit
GrossProfit
520127724
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
10927330
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
20329684
us-gaap Labor And Related Expense
LaborAndRelatedExpense
21950792
us-gaap Labor And Related Expense
LaborAndRelatedExpense
39570896
CY2022Q2 us-gaap Selling Expense
SellingExpense
288774
us-gaap Selling Expense
SellingExpense
509961
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
279085
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
12821414
us-gaap Professional Fees
ProfessionalFees
579084
us-gaap Professional Fees
ProfessionalFees
68490826
CY2023Q2 tmna Bank Fees And Charges
BankFeesAndCharges
237
CY2022Q2 tmna Bank Fees And Charges
BankFeesAndCharges
360373
tmna Bank Fees And Charges
BankFeesAndCharges
1774
tmna Bank Fees And Charges
BankFeesAndCharges
996420
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
106876493
us-gaap Depreciation And Amortization
DepreciationAndAmortization
213617432
CY2023Q2 tmna General And Administrative Expenses
GeneralAndAdministrativeExpenses
14826
CY2022Q2 tmna General And Administrative Expenses
GeneralAndAdministrativeExpenses
2869859
tmna General And Administrative Expenses
GeneralAndAdministrativeExpenses
7752555
tmna General And Administrative Expenses
GeneralAndAdministrativeExpenses
3708772
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
57
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
47455
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
11221478
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
143546654
us-gaap Operating Expenses
OperatingExpenses
30284205
us-gaap Operating Expenses
OperatingExpenses
326941762
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11221478
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
122023391
us-gaap Operating Income Loss
OperatingIncomeLoss
193185962
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
297782
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
137938
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
750744
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
323736
CY2023Q2 us-gaap Interest Expense
InterestExpense
298831
CY2022Q2 us-gaap Interest Expense
InterestExpense
23726
us-gaap Interest Expense
InterestExpense
592667
us-gaap Interest Expense
InterestExpense
23726
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1049
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
114212
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
158077
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
300010
CY2023Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-11222527
CY2022Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
122137603
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-30126128
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
193485972
CY2022Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
49584310
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
88283139
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-11222527
CY2022Q2 us-gaap Profit Loss
ProfitLoss
72553293
us-gaap Profit Loss
ProfitLoss
-30126128
us-gaap Profit Loss
ProfitLoss
105202833
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-970419
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1310532
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11222527
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
71582874
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30126128
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
103892301
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1227516221
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1227516221
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1227516211
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1227516211
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1221262021
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1221262021
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1221082509
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1221082509
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1206338527
tmna Vesting Of Deferred Stock Compensation
VestingOfDeferredStockCompensation
20702450
us-gaap Net Income Loss
NetIncomeLoss
-301256128
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1196914849
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1197786151
CY2023Q2 tmna Vesting Of Deferred Stock Compensation
VestingOfDeferredStockCompensation
10351225
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11222527
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1196914849
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
596319976
tmna Vesting Of Deferred Stock Compensation
VestingOfDeferredStockCompensation
101223986
us-gaap Net Income Loss
NetIncomeLoss
105202833
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1310532
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
801436263
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
700668904
CY2022Q2 tmna Vesting Of Deferred Stock Compensation
VestingOfDeferredStockCompensation
29184485
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
72553293
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-970419
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
801436263
us-gaap Profit Loss
ProfitLoss
-30126128
us-gaap Profit Loss
ProfitLoss
105202833
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
213617432
tmna Stock Issued During Period Value Issued For Service
StockIssuedDuringPeriodValueIssuedForService
66500000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
20702450
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
12723986
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
7700000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-95910
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-45564659
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
421025
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2174786
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-654556357
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
77047330
tmna Increase Decrease In Value Added Tax
IncreaseDecreaseInValueAddedTax
6177847
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-10477879
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30083
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
89216821
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
22500
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3049945
tmna Payments On Advances From Related Party
PaymentsOnAdvancesFromRelatedParty
40000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17500
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92266766
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-393012
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12583
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
985
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
128367605
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13568
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104137120
us-gaap Income Taxes Paid
IncomeTaxesPaid
100262236
us-gaap Interest Paid Net
InterestPaidNet
4000
tmna Stock Issued Under Incentive Plan To Employees
StockIssuedUnderIncentivePlanToEmployees
22000000
us-gaap Stock Issued1
StockIssued1
66500000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
6191510
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.98
CY2023Q2 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
1215241000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of Estimates</b>—The preparation of financial statements in accordance with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Although we believe the estimates and assumptions used in preparing these financial statements and related notes are reasonable in light of known facts and circumstances, actual results could differ from those estimates.</p>
tmna Common Stock Number Of Classes
CommonStockNumberOfClasses
2
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-30126128
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
105202833
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
818796244
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
416095565
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
788670116
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
521298398
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
0
CY2023Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2022Q2 tmna Percentage Of General Allowance On Accounts Receivable
PercentageOfGeneralAllowanceOnAccountsReceivable
0.03
tmna Bad Debt Expense
BadDebtExpense
47000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2022Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5175613
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.250
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-25305997
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.250
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-5175613
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.250
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-25305997
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.250
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
100856938
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
90505713
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
100856938
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
90505713
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
98200000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
16732916
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
10541406
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.96
CY2023Q2 tmna Loans And Other Receivables Due From Related Parties Current
LoansAndOtherReceivablesDueFromRelatedPartiesCurrent
3631949
CY2022Q4 tmna Loans And Other Receivables Due From Related Parties Current
LoansAndOtherReceivablesDueFromRelatedPartiesCurrent
3713179
CY2022Q4 tmna Loans And Other Receivables Due From Advances To Related Parties Current
LoansAndOtherReceivablesDueFromAdvancesToRelatedPartiesCurrent
58489
CY2022Q4 us-gaap Related Party Transaction Rate
RelatedPartyTransactionRate
0.05
CY2023Q2 tmna Notes Receivables Due From Related Parties Current
NotesReceivablesDueFromRelatedPartiesCurrent
16426744
CY2022Q4 tmna Notes Receivables Due From Related Parties Current
NotesReceivablesDueFromRelatedPartiesCurrent
15866000
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
20058693
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
19637668
CY2023Q2 tmna Cash And Cash Equivalents
CashAndCashEquivalents
14000
CY2022Q4 tmna Cash And Cash Equivalents
CashAndCashEquivalents
1000
CY2023Q2 us-gaap Accounts Payable Interest Bearing Current
AccountsPayableInterestBearingCurrent
955364
CY2022Q4 us-gaap Accounts Payable Interest Bearing Current
AccountsPayableInterestBearingCurrent
1003787
CY2023Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4485355
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2948013
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1020248
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
334381
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6460967
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4286181
CY2023Q2 tmna Expenses Paid By Related Party On Behalf Of Company
ExpensesPaidByRelatedPartyOnBehalfOfCompany
465000
CY2022Q4 tmna Expenses Paid By Related Party On Behalf Of Company
ExpensesPaidByRelatedPartyOnBehalfOfCompany
505000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001410578-23-001928-index-headers.html Edgar Link pending
0001410578-23-001928-index.html Edgar Link pending
0001410578-23-001928.txt Edgar Link pending
0001410578-23-001928-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmna-20230630.xsd Edgar Link pending
tmna-20230630x10q.htm Edgar Link pending
tmna-20230630x10q001.jpg Edgar Link pending
tmna-20230630xex31d1.htm Edgar Link pending
tmna-20230630xex31d2.htm Edgar Link pending
tmna-20230630xex32d1.htm Edgar Link pending
tmna-20230630xex32d2.htm Edgar Link pending
tmna-20230630_def.xml Edgar Link unprocessable
tmna-20230630_cal.xml Edgar Link unprocessable
tmna-20230630_lab.xml Edgar Link unprocessable
tmna-20230630_pre.xml Edgar Link unprocessable
tmna-20230630x10q_htm.xml Edgar Link completed